Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.60 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19361722 | 0.86 | TAAR1 (0.60) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL2457093 | 0.86 | CYP3A4 (0.62) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL8953616 | 0.86 | CYP3A4 (0.62) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL9126115 | 0.86 | CYP3A4 (0.60) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL7516082 | 0.86 | CYP3A4 (0.62) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL30052034 | 0.86 | CYP3A4 (0.62) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL16356746 | 0.84 | TAAR1 (0.62) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL11698405 | 0.84 | CYP3A4 (0.56) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL11000389 | 0.83 | CYP3A4 (0.57) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL27963133 | 0.81 | CYP3A4 (0.56) | CYP3A4TAAR1SLC6A4SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3225627-A1 | TRIPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Northwest University (CN) | 2017-10-04 | — | — | EP | disclosed |
| US-20170267718-A1 | TRIPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | NORTHWEST UNIVERSITY (CN) | 2017-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267718-A1 | TRIPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | VIP, PREP, ACE | CYP3A4 2295/4885TAAR1 2612/4885SLC6A4 2556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.